Logo image
Non-Hodgkin’s Lymphoma
Book chapter

Non-Hodgkin’s Lymphoma

Theodore E. Yaeger, Jiade J. Lu and Luther W. Brady
Radiation Oncology, pp 399-413
2008

Abstract

Clin Oncol Follicular Lymphoma International Prognostic Index Marginal Zone Lymphoma Radiat Oncol Biol Phys
Non-Hodgkin’s lymphoma (NHL) is generally considered a systemic disease process in 80%–85% of patients. The majority are of B-cell origin, with a wide variety of clinical phenotypes. A multi-disciplinary approach for management is appropriate for most cases. Chemotherapy is the mainstay of treatment in the majority of symptomatic presentations. External-beam radiation therapy is an important treatment modality for limited, localized indolent NHL, as well as in stage I and II aggressive diseases. Immunotherapy (rituximab) is often added to chemotherapy either concurrently or sequentially for CD20-positive disease. This chapter focuses on the management of indolent and aggressive non-Hodgkin’s lymphoma, particularly follicular lymphoma, marginal zone lymphoma, gastric MALT, and diff use large-cell lymphoma, and examines: Recommendations for diagnoses and staging proceduresThe staging systems and prognostic factorsTreatment recommendations for indolent NHL and the sup- porting peer-reviewed scientific evidenceTreatment recommendations for gastric MALT and the sup- porting peer-reviewed scientific evidenceThe use of systemic chemotherapy and immunotherapy in combination with localized radiation therapy for definitive treatment of stage I and II aggressive NHLFollow-up care and surveillance of survivors

Metrics

13 Record Views

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Oncology
Radiology, Nuclear Medicine & Medical Imaging
Logo image